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CHAPTER 1: INTRODUCTION
Herpes Simplex Virus 1
The Herpesviridae are a family of double-stranded DNA (dsDNA) herpesviruses that cause
a plethora of human and animal diseases. There are three subfamilies of Herpesviridae:
Alphaherpesvirinae, Betaherpesvirinae, and Gammaherpesvirinae. Although these subfamilies
differ in their host tropism and morphology, they share many commonalities amongst their virion
structures and viral DNA replication mechanisms (Akhtar, Jihan; Shukla, 2009; Kukhanova,
Korovina, & Kochetkov, 2014; Salameh, Sarah; Sheth, Urmi; Shukla, 2012). The most prevalent
herpesvirus, Herpes Simplex Virus Type 1 (HSV-1), is a member of the Alphaherpesvirinae
subfamily. Alphaherpesviruses are lytic viruses characterized by their short replication cycles,
their ability to infect various cell types, and their ability to establish latency in the sensory ganglia
(Kukhanova et al., 2014). Approximately 67% of the world’s population is seropositive for HSV1. Like the other Herpesviridae members, HSV-1 is an enveloped dsDNA virus in which its viral
genome is encased within an icosahedral capsid, and a lipid bilayer envelope surrounds the capsid
(Kukhanova et al., 2014; Spear & Longnecker, 2003). HSV-1 is a ubiquitous human pathogen that
is primarily associated with a common cold sore. However, the virus may also cause more
advanced pathology, such as encephalitis and blindness. The host’s immunocompetency
establishes the severity and clinical presentation of viral infection; therefore, HSV-1 is more severe
amongst elderly and neonatal patients who are immunosuppressed (Chayavichitsilp, Buckwalter,
Krakowski, & Friedlander, 2009; Grinde, 2013). Many HSV infections can be successfully treated
with the drug Acyclovir; however, resistance to treatment is on the rise (Bacon, Levin, Leary,
Sarisky, & Sutton, 2003; Frobert et al., 2014). Successful antiviral strategies have targeted the
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elements of viruses’ replication machinery. Treatment will aid in controlling replication, active
infection, and the spread of the virus from host-to-host. The development of new therapies against
HSV will require a better understanding of its replication mechanisms.

HSV-1 Lifecycle
Herpesviruses have two lifecycle phases: 1) the lytic lifecycle, characterized by active
replication and 2) latency, in which there is no production of new viral particles, yet there is a
possibility that the lytic cycle will reactivate (Weidner-Glunde, Magdalena; Kruminis-Kaszkiel,
Ewa; Savanagouder, 2020). One hallmark of herpes infections is their ability to establish latent
infections that can be reactivated later. Latency enables the virus to develop a lifetime infection
within the host’s peripheral neurons (Singh & Tscharke, 2020). Asymptomatic reactivation can
lead to the shedding of the virus and transmission to a partner. Viral shedding is dependent on the
virus's ability to replicate its genome and produce infectious virus (Salameh, Sarah; Sheth, Urmi;
Shukla, 2012; Singh & Tscharke, 2020). The lytic viral life cycle (Fig. 1.1) consists mainly of the
following steps: viral entry into the host cell, nuclear trafficking, expression of viral genes,
replication, virion packaging, egress, and release of the new viral particles. HSV-1 expresses
glycoproteins gB, gC, gD, gH, and gL, which help facilitate host cell entry. Once inside the cell,
the HSV capsid is translocated to the nucleus where the DNA is ejected from the capsid through
the nuclear pore into the nucleus. After the viral DNA is replicated within the nucleus, transcription
leads to the production of mRNA, mRNA is translated into protein in the cytoplasm, proteins come
back into the nucleus, and capsids are assembled. The DNA is packaged into the newly assembled
capsid, and the new viral progeny can then be released from the host cell (Kukhanova et al., 2014;
Salameh, Sarah; Sheth, Urmi; Shukla, 2012).
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Figure 1.1 HSV-1 Lytic Lifecycle. 1. HSV’s lytic lifecycle begins with the virus
binding to the host’s cell receptor. 2. The viral envelope fuses with the host cell plasma
membrane. 3. The nucleocapsid enters the cytoplasm and is trafficked to the nucleus.
The viral DNA is ejected from the capsid through the nuclear pore into the nucleus. 4.
Viral DNA is replicated. 5. mRNAs are produced during transcription in the nucleus
and are translated into viral proteins in the cytoplasm. 6. DNA is packaged into newly
assembled nucleocapsids. 7. The nucleocapsid undergoes envelopment and egresses
from the nucleus through the cytoplasm. 8. New viral particles are released from the
cell. A few aspects of this figure, such as transcription and the translation of viral
proteins, were adapted from Kukhanova et.al, 2014. This figure was created and drawn
by Jaliyah Peterson.
HSV-1 Replication
The HSV genome is 152 kbp and contains two regions, unique long (UL) and unique short
(US), that are each bordered by inverted repeat sequences. As illustrated in Figure 1.2, the HSV
genome has three origins of replication, OriL, and OriS. OriL is located within the UL region, while
OriS is present twice within the viral genome's repeated c region (Hayward, Jacob, Wadsworth, &
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Roizman, 1975; Sheldrick & Berthelot, 1975). HSV requires head-to-tail concatemer formation
for the production of viral progeny. The virus has to replicate and then package a unit genome that
comes into the cell. Replication results in tandem repeats (concatemer) from which single unit
genomes can be cleaved at UL-US sequence junctions during packaging (Lo Piano, MartínezJiménez, Zecchi, & Ayora, 2011; S. K. Weller & Coen, 2012; Sandra K Weller & Sawitzke, 2014).
As soon as DNA synthesis can be detected, the repeated segments of the UL and US regions undergo
genomic inversion relative to one another. The inverted repeats, or repetitive DNA, create the
longer-than-unit-length concatemers that are recognized by the packaging machinery. It is believed
that recombination, initiated by double-strand breaks in the genome, plays a role in inducing the
genomic inversion during HSV replication (Wilkinson & Weller, 2003). Figure 1.4 illustrates a
model of the proposed recombination-dependent DNA synthesis.

HSV viral genome
UL

a b
oriL

capsid
b' a' c'

US

ca

?

oriS

Concatemer

Figure 1.2. Pictured is an illustration (adapted from Katherine DiScipio) of the HSV
linear genome and the concatemer that is generated in order to produce new viral
particles. The left side of the figure shows the linear HSV viral genome. The sequence
of the genome is arranged as ab-UL-b’a’c’-US-ca. Also pictured are the three origins
of replication. OriL lies within the UL segment and OriS appears twice within the US
segment. An unknown mechanism generates head-to-tail concatemers that allows the
genome to be packaged, as shown on the right.

4

There are seven essential HSV-1 DNA replication proteins: ICP8, UL5, UL52, UL8, UL9,
UL30, and UL42. UL9 is the origin binding protein that plays a role in facilitating the initiation of
HSV DNA synthesis. ICP8 is the single-strand binding protein that is essential for HSV viral
growth, and it is required for viral DNA synthesis and regulation of viral gene expression. UL30
is HSV’s DNA polymerase, and UL42 is the polymerase accessory protein; the DNA polymerase
complex, composed of UL30 and UL42, is responsible for both leading and lagging-strand DNA
synthesis. Lastly, UL5 is the DNA helicase, UL52 is the primase, and UL8 is a member of the
helicase/primase complex. Together, UL5, UL52, and UL8 compose the heterotrimeric
helicase/primase complex responsible for coordinating replication fork activities (S. K. Weller &
Coen, 2012).
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Overview of ICP8

ICP8, the major ssDNA-binding protein

P8 is a conserved multifunctional 128 kDa zinc
ICP8 (Fig. 1.3), a 128-kDa zinc metalloprotein,
talloprotein

is a central
player
in all stages
of HSV-1
P8 is an essential
protein
for HSV-1
replication
andDNA
the
mation of replication compartments
replication processes and acts as a hub for proteinnown biochemical functions include:
protein interactions at the replication fork (Gupte, Olson,

i. ssDNA Binding Protein (SSB)
Ruyechan,
1991). ICP8, like other replicative single-Bind&ssDNA
cooperatively
-Stimulates replication proteins
strand binding proteins (SSBs), binds single-strand
ii. Single Strand Annealing Protein (SSAP)
iii. Promote Helix Destabilization
DNA (ssDNA) cooperatively and non-specifically,
iv. Hub for protein protein interactions

Darwish et al., 2015
PDB: 1URJet al 2005
Mapelli

PDB: 1URJ

stabilizes ssDNA at the replication fork, and Figure 1.3. ICP8’s crystal structure. As
shown by this ribbon diagram, ICP8’s crystal
interacts with and stimulates other replication structure consists of a head (red), neck (yellow)
and shoulder (blue) region. It also has a Cproteins (such as UL9, UL30, and the helicase- terminal helical domain (purple) and FW
hydrophobic pocket (green). Not pictured in
primase complex) (P E Boehmer & Lehman, this figure is ICP8’s 60 aa-disordered domain
that contains the linear FNF motif. The crystal
1993; Falkenberg, Bushnell, Elias, & Lehman, structure was solved by Mapelli et al., 2005.
This figure was created by Anthar Darwish
1997; T. R. Hernandez & Lehman, 1990; (Darwish et al., 2015).
O’Donnell, Elias, Funnell, & Lehman, 1987; Ruyechan, 1983; Ruyechan & Weir, 1984; T. J.
Taylor & Knipe, 2004). An example of ICP8’s ability to stimulate other replication proteins is its
ability to work in conjunction with the origin binding protein UL9 to activate DNA synthesis at
the origins of replication (P E Boehmer, Craigie, Stow, & Lehman, 1994; Paul E Boehmer &
Lehman, 1993). ICP8 exhibits helix-destabilizing properties and stimulates HSV polymerase and
helicase/primase activities during the elongation phase of DNA synthesis (P E Boehmer, 1998; P
E Boehmer, Dodson, & Lehman, 1993; Hamatake, Bifano, Hurlburt, & Tenney, 1997). It has been
suggested that ICP8 also has a role in coordinating leading and lagging strand synthesis at the
replication fork (Falkenberg, Lehman, & Elias, 2000). Additionally, ICP8 is an essential driver in
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the reorganization of the nucleus in HSV infected cells and the formation of pre-replicative sites
and replication compartments (RCs) (de Bruyn Kops & Knipe, 1988; Liptak, Uprichard, & Knipe,
1996; Lukonis & Weller, 1996; Quinlan, Chen, & Knipe, 1984). ICP8 is distinct from some SSBs
in that it also functions to stimulate annealing of complementary ssDNA, resulting in its
classification as a single strand annealing protein (SSAP) (Bortner, Hernandez, Lehman, &
Griffith, 1993; Dutch & Lehman, 1993). ICP8 protein-protein interactions (PPIs) are thought to
aid in the initiation of DNA synthesis, be essential for viral DNA replication, mediate filament
formation, and contribute to the annealing activities of ICP8 (Darwish, Grady, Bai, & Weller,
2015; S. K. Weller & Coen, 2012).
During HSV replication, the nucleus of an infected cell is reorganized, and intranuclear
domains, RCs, are formed. ICP8 filament formation was found to be essential for RC formation
(Darwish et al., 2015). ICP8 binds ssDNA cooperatively, which enhances its ability to form
filaments. ICP8 forms thin nucleoprotein filaments on ssDNA, and in the absence of DNA, it forms
double-helical filaments (Makhov & Griffith, 2006; Makhov et al., 2009; O’Donnell et al., 1987;
Tolun, Makhov, Ludtke, & Griffith, 2013). The Weller lab also suggested that HSV DNA
replication involves the formation of an ICP8-ssDNA nucleoprotein filament during the annealing
of complementary ssDNA (Weerasooriya, DiScipio, Darwish, Bai, & Weller, 2019).

ICP8 as a SSAP
Annealing is the process by which two complementary strands of ssDNA come together to
form dsDNA. Recent evidence from the Weller lab suggests that ICP8-catalyzed annealing may
play an essential role during viral DNA synthesis (Weerasooriya et al., 2019). We suggest that
annealing of complementary strands begins with the formation of an ICP8-ssDNA nucleoprotein
filament. Next, two nucleoprotein filaments bound to complementary ssDNA are believed to come
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together to form an intertwined annealing intermediate, resulting in the formation of dsDNA
(Makhov & Griffith, 2006; Weerasooriya et al., 2019).
Recombination Dependent Replication (RDR) is an emerging model for HSV-1 DNA
synthesis and the role of ICP8 annealing activity during HSV-1 DNA replication (Fig. 1.4). The
model begins with a free genome end or double-strand break that was created during infection.
The double-strand break or free genome end is resected by a 5′-to-3′ exonuclease (UL12) and ICP8
coats the resulting 3′ ssDNA overhang. Next, ICP8 promotes annealing of the resulting 3′-ssDNA
overhang to an active replication fork to prime DNA synthesis. Additionally, since the HSV
genome that enters the cell has nicks and gaps (Smith, Reuven, Mohni, Schumacher, & Weller,
2014), ICP8 could also prime DNA synthesis by promoting annealing at a gap in the genome,
ultimately leading to the formation of complex, branched DNA and intermediates (Weerasooriya
et al., 2019; Sandra K Weller & Sawitzke, 2014; Wilkie, 1973; Wilkinson & Weller, 2003).
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Figure 1.4. Model for Recombination-Dependent DNA Synthesis. This model for
recombination-dependent DNA synthesis was adapted from Katherine DiScipio. The model
starts with a double strand break that is resected by UL12 (green). ICP8 (yellow) then coats
the 3’-ssDNA and promotes annealing of the 3’ overhang to either an active replication fork
or a gap in the genome. This jumpstarts strand displacement synthesis and leads to the
generation of branched intermediates.

Thesis Objectives

Overall, HSV-1 DNA replication is a complex process that involves seven viral DNA
replication proteins; however, this thesis will focus on ICP8. This work seeks to provide insight
into aspects of ICP8 and its various contributions to the mechanism of HSV-1 DNA replication.
We will use genetic and biochemical methods to explore the roles of ICP8-ICP8 interactions
during annealing. We will map residues that contribute to ICP8 filament formation through the
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analysis of viral complementation of an ICP8-null virus. We will then probe five conserved ICP8
residues in the QF shoulder region of ICP8 for their roles in annealing.

SPECIFIC AIMS

Aim 1. Test the hypothesis ICP8 oligomerization is necessary for HSV function, via
intermolecular interactions between its neck and C-THD regions. In the crystal structure of
ICP8, the C-THD of one monomer contacts a concave surface at the back of the head and neck
region of a neighboring molecule. Three pairs of surface-exposed residues visualized in the
structure are suggested to promote this interaction (N839-Y1096, K820-D1094, and D1087R922). We will introduce mutations into each of the six residues and characterize mutants for their
ability to complement the growth of an ICP8 null-virus, HD-2.
Aim 2. Test the hypothesis that conserved residues at the front of the neck and in the shoulder
region of ICP8 distinguish domains essential for ssDNA annealing. Our preliminary studies
showed that a QF mutant, located in the shoulder region of ICP8, retained replicative SSB
functions but was unable to promote ssDNA annealing and viral DNA replication. These results
indicated that the QF region is essential for ICP8’s annealing function. Therefore, we will
investigate conserved ICP8 residues (R701, R704, R712, R713, and R714) in the QF shoulder
region of ICP8 for their roles in annealing.

We expect to define requirements for linear interactions and examine the consequences of
disrupting linear interfaces, regarding in vitro properties of ICP8 as well as phenotypes observed.
In addition, we expect that many of these residues being tested for annealing activities will exhibit
similar phenotypes to QF and will allow us to propose a region within the shoulder that is
10

responsible for annealing-specific interactions. The results of this study may lead to the design of
drugs for improved, non-resistant treatments of HSV-1.

Overarching hypothesis: We hypothesize that ICP8-ICP8 interactions are necessary for viral
DNA replication and the annealing of complementary ssDNA.
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CHAPTER 2: MATERIALS AND METHODS
The methods presented in this chapter derive primarily from the following references ((Darwish
et al., 2015; Grady, Bai, & Weller, 2014; Weerasooriya et al., 2019).

Cell Cultures and Viruses
African green monkey kidney (Vero) cells from the American Type Culture Collection were
maintained in Dulbecco's modified Eagle's medium (DMEM). The DMEM was enhanced with 5%
fetal bovine serum (FBS) and 0.1% penicillin-streptomycin. The ICP8-complementing S2 cells
were provided by David Knipe (Harvard University, Boston, MA). The S2 cells were kept under
G418 selection (400 μg/ml) and were maintained in DMEM supplemented with 5% FBS and 0.1%
penicillin-streptomycin. Both cell cultures (Vero and S2) were sustained in a humidified
atmosphere containing 5% CO2 at 37ºC. The HSV-1 KOS strain was used as the wild-type (WT)
in all experiments. David Knipe (Harvard University, Boston, MA) provided the ICP8-null virus,
HD-2, which contained a lacZ insertion mutation in the ICP8 gene.

DNA Constructs and Mutagenesis

Site-Directed Mutagenesis (SDM) was performed to construct alanine substitution mutations in
the ICP8 expression plasmid, pSAK-ICP8, for mammalian expression and in the pFastBac-1
vector for the production of recombinant baculoviruses, respectively. QuikChange II XL SiteDirected Mutagenesis Kit (Agilent Technologies) was used by following the manufacturer’s
suggested protocol.

Transfection
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Vero cells were plated in a 12-well plate and grown to 70-80% confluency overnight. They were
then transiently transfected with 50 ng/uL of the WT or mutant ICP8 plasmid and 500 ng of pUC19
(carrier DNA) using Lipofectamine Plus Reagent (Invitrogen). After mixing the reagents with the
DNA plasmids, the plates were incubated at 37ºC for 3 hours. After 3 hours, 0.4 mL of DMEM
media supplemented with 10% FBS was added to each well. The transfection and incubation
resumed at 37ºC for 16-18 hours.
Western Blot Analysis
Transfected Vero cell lysates were collected for Western Blot to test protein expression of the WT
and ICP8 mutants. The lysates were run on a 10% SDS-PAGE gel. After gel electrophoresis, a wet
transfer was performed overnight. The PDVF membrane from the transfer was divided at the 75
kDa line such that the top half could be used to detect ICP8 (128 kDa) and the bottom half used
for the detection of actin. The membranes were blocked in 5x milk in TBST for 1 hour, incubated
with primary mouse anti-actin antibody (dilution, 1:10,000) or primary rabbit polyclonal 3-83 antiICP8 antibody (dilution, 1:10,000) for 2 hours, and incubated with secondary ECL-anti-mouse
antibody (used for actin; dilution 1:20,000) and secondary ECL-anti-rabbit antibody (used for
ICP8; dilution, 1:20,000) for 30 minutes. The membranes were then sprayed with a developer
solution and imaged using the ChemiDoc MP Imaging System (Bio-Rad).

Immunofluorescence analysis
Immunofluorescence (IF) analysis was performed to visualize protein nuclear localization and
replication compartment formation within the cells. Vero cells were plated to 70-80% confluency
in a 12-well culture plate, grown overnight on glass coverslips, then transfected the following day.
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Post-transfection, the cells were washed with phosphate-buffered saline (PBS), fixed with 4%
paraformaldehyde (PFA) for 15 minutes, and permeabilized using 1% Triton-x100 for 10 minutes.
Cells were blocked in 3% normal goat serum for 1 hour and were incubated with the following
antibodies: mouse anti-ICP8 (monoclonal, Santa Cruz) primary antibody (dilution, 1:1250) and
goat anti-mouse 488 secondary antibody (dilution, 1:500). Cells were then stained with Hoechst
stain (dilution, 1:10,000 in PBS) and mounted on slides for imaging.
Transient Complementation Assay
Vero cells were plated to 70-80% confluency in a 12-well plate, grown overnight, and transfected
the following day. Post-transfection, cells were infected with HD-2 (ICP8 null-virus) at a
multiplicity of infection (MOI) of 3 PFU/cell for 1 hour at 37°C. After 1 hour, cells were washed
with PBS, the medium was replaced with DMEM supplemented with 5% FBS, and the cells were
left to continue the infection for 24 hours. At 24 hours post-infection, the cells and growth media
were collected and were frozen at 80°C and thawed at 37°C three times. Serial 10-fold dilutions
of the virus were prepared, and the dilutions were added on plates containing S2 complementing
cells that were prepared the previous day and grown overnight. After incubating for 1 hour, the
inoculum was removed from the plate and replaced with media containing 1% Human Serum/2%
FBS /1x PenStrep /DMEM. The average percent complementation was calculated using three
independent experiment trials.

Replication Compartment Assay
Vero cells were plated on glass coverslips and grown to ∼80% confluency overnight in a 12-well
culture plate. Cells were transfected the following day, then ~16-18 hours post-transfection the

14

cells were infected with HD-2 at a MOI of 20. At 8 hours post-infection, the cells were fixed in
4% PFA for 15 minutes, washed with PBS, and permeabilized using 1% Triton-x100 for 10
minutes. Cells were blocked in 3% normal goat serum for 1 hour and were incubated with the
following antibodies: rabbit anti-ICP8 (dilution, 1:000) and mouse anti-ICP4 (dilution, 1:200)
primary antibodies; goat anti-mouse 594 (dilution, 1:500) and anti-rabbit 488 (dilution, 1:500)
secondary antibodies. Cells were then stained with Hoechst stain (dilution, 1:10,000 in PBS) and
mounted on slides for imaging. Images were taken on Zeiss LSM 880 Meta confocal microscope.
Quantification of Viral DNA Synthesis
Vero cells were plated in 60-mm dishes and grown to 80% confluency overnight. The following
day the cells were transfected with 300 ng/uL of WT or mutant ICP8 plasmid, 1.7 μg of pUC19
(carrier DNA), and PLUS reagent. Post-transfection, ~16-18 hours, cells were infected with HD2 at a MOI of 5 PFU/cell and harvested 24 hours post-infection. The total DNA was isolated
using Qiagen Blood and Tissue genomic DNA isolation kit according to the manufacturer’s
suggested protocol. The DNA concentrations were determined using Nanodrop (Thermo Fisher
Scientific), and samples were diluted to 50 uL aliquots of 10 ng/uL in a PCR tube strip for a
quantitative polymerase chain reaction (qPCR) analysis.

In-Fusion Cloning
Instead of using SDM to insert the mutations into the pFastBac vector, we opted to use in-fusion
cloning, which allowed directional cloning of the ICP8 gene into the pFastBac vector. We used
Takara Bio’s In-Fusion Cloning Design Tool in which we input the full DNA sequence of the
pFastBac-ICP8 vector, selected EcoRI as our restriction enzyme site, and designed the primers
that would be used for cloning.
15

The below primers were used to PCR amplify the ICP8 gene with the mutation of interest from
our previously made pSAK constructs along with 15bp homology on either end to the pFastBac
vector at the desired insertion location. The in-fusion protocol was then used to generate these
constructs.
Primer Name
ICP8 infusion_F
ICP8 infusion_R

Primer Sequence (5' to 3')

Code

GAAGCGCGCGGAATTATGGAGACAAAGCCCAAGACGG

JP11

GTAGGCCTTTGAATTTCACAGCATATCCAACGTCAGG

JP12

Figure 2.1. In-Fusion Primers. Above are the forward and reverse primer sequences received
from Takara Bio’s In-Fusion Cloning Design Tool. These primers were used in a PCR reaction to
begin the production of the alanine substitution mutations in the pFastBac expression vector.

Baculovirus Construction
To construct the baculovirus insect cell expression system that would be used for protein
purification, the pFastBac-ICP8 mutant plasmids were transformed into DH10Bac cells. The
recombinant bacmid DNA was then purified, and the DNA concentrations were determined using
Nanodrop. SF9 insect cells were transfected using 3-6 ug of WT or mutant bacmid DNA, Grace’s
minimal medium, and Cellfectinin II. The cells incubated at 27ºC for 5 hours, the transfection
mixture was aspirated, fresh SF900 II media was added, then the cells were left to incubate for 34 days at 27ºC. The samples were harvested ~48-50 hours post-infection, and expression of the
harvested ICP8 mutants’ stock was tested during titration. For titration, SF9 cells were infected
with a series of viral dilutions (300 uL total volume). The volumes of virus stock added for each
mutant were: 25 uL, 50 uL, 100 uL, 200 uL, 300 uL. After infecting the cells for ~65 hours, the
samples were harvested and ran on a 10% SDS PAGE gel.
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Protein purification
Infected insect cell pellets were resuspended in a 1x protease inhibitor and a swelling buffer (for
cell resuspension and nuclear extraction) containing 10 mM Tris-HCl [pH 7.5], 10 mM KCl, and
1.5 mM MgCl2. The pellets were then homogenized, and the remaining pellet nuclei were
centrifuged at 5000 xg for 8 minutes at 4ºC. The supernatant was removed, and the nuclei were
resuspended in an extraction buffer containing a swelling buffer with 1.2 M NaCl and 1x protease
inhibitor to extract nuclear proteins. To harvest the extracted nuclear proteins, the samples were
centrifuged at 32,000 rpm for 40 minutes at 4oC in Ti70 rotor, and the supernatant was collected.
The supernatant was dialyzed overnight at 4oC in 1.5 L Buffer A containing 20 mM HEPES-KOH
[pH 7.5], 100 mM NaCl, 10% Glycerol, 1 mM DTT and 0.1 mM EDTA. After dialysis, the samples
were transferred to an ultracentrifuge tube and were spun in Ti70 for 15 minutes at 15,000 rpm.
Samples were filtered using a small PVDF 45 mm filter before loading into a syringe for loading
and injection. Samples were run on a Column Hiload 16/10 SP-Sepharose cation-exchange
column. The purified protein fractions were collected, analyzed on a 10% SDS-PAGE gel and
visualized by Coomassie blue staining. Protein fractions with the highest purity were dialyzed in
Buffer A overnight then stored at −80°C.

Annealing of Complementary ssDNA

To test annealing of complementary ssDNA, a pSAK plasmid pUC19 (25 ng/uL) was linearized
by digestion with HindIII to be used as the DNA substrate. The DNA was heat-denatured by
boiling for 5 minutes using a 95oC water bath and then snap cooled on ice for 15 minutes. While
cooling the DNA, tubes were prepared with a 10 uL quenching solution containing 8 M Urea (5
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uL/10 uL rxn), 0.5 M EDTA (3 uL/10 uL rxn), and dH2O (2 uL/10 uL rxn). 30 uL reactions were
performed using an 1x annealing buffer containing 20 mM Tris-HCl [pH 7.5], 100 mM NaCl, 6
mM MgCl2, 1 mM DTT, 0.1 mg/mL BSA, and either the WT or mutant ICP8 protein. To initiate
the reaction, 2 uL of the heat-denatured ssDNA was added, mixed, and incubated in a 37oC water
bath for 30 minutes. After 30 minutes, the reaction was added to the quenching solution, and the
samples were digested with proteinase K (20 mg/mL) in a 42oC water bath for 5 min. 1x TE [pH
7.5] (provided with Pico-green reagent) was pipetted into each reaction tube. This reaction was
then transferred into a black 96-well plate (Fluotrac 200 Lot E 10 03 0BB, 2014-03). Pico Green
reagent [Molecular probes Cat # S11494] (diluted 1:300 in 1x TE pH 7.5) was added to each well
and incubated for 2-5 minutes. Values were obtained from the plate reader at standard fluorescein
wavelengths (excitation ~480 nm, emission ~520 nm).
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CHAPTER 3: EXPLORING RESIDUES ESSENTIAL FOR HSV ICP8 SELFINTERACTION THROUGH THE ANALYSIS OF MUTANTS
Jaliyah Peterson and Katherine DiScipio
Contributions: J.P. performed Western blot analysis, IF analysis, and complementation assay.
K.D. performed protein purification, DNA binding analysis, electron microscopy (EM), and an
annealing assay.

INTRODUCTION
During HSV-1 replication, ICP8 is compartmentalized within large, intranuclear subdomains known as replication compartments (RCs) (Quinlan et al., 1984). Viral DNA synthesis
and viral gene expression occur within RCs (de Bruyn Kops & Knipe, 1988). ICP8 cooperatively
binds ssDNA during viral DNA replication and was therefore designated as a single strand DNA
binding protein or SSB (Dudas & Ruyechan, 1998). When one ICP8 molecule binds to ssDNA, it
increases the binding affinity of an additional molecule of ICP8 to bind adjacently, classifying the
binding as cooperative. ICP8, bound to ssDNA in this cooperative manner, is held in an extended
configuration, ultimately forming a nucleoprotein filament that resembles “beads on a string”
(Makhov & Griffith, 2006; Ruyechan, 1983; Tolun et al., 2013). As previously described by
O’Donnell et al., we have observed that in the absence of DNA, ICP8 can also assemble into
double-helical filaments in vitro (O’Donnell et al., 1987). Published data by Darwish et al. revealed
that ICP8 mutant proteins defective in double-helical filament formation were also defective in the
viral growth of an ICP8-null virus and unable to form replication compartments. This data
indicates that the ability of ICP8 to interact with itself is essential for viral replication (Darwish et
al., 2015).
In this chapter, we seek to analyze how ICP8 molecules interact with each other to form a
filament. ICP8-ICP8 interactions are essential for maintaining ICP8 protein functions, and we want
to identify regions of ICP8 that contribute to these interactions. The published crystal structure of
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ICP8 (Fig. 3.1) shows that it contains four major structural regions: head, neck, shoulder, and cterminal helical domain (C-THD). The C-THD has a 60-aa disordered domain that includes a
conserved linear FNF motif (aa 1142 to 1144) that is not present in the crystal structure as the
structure was solved for ICP8 mutant in which this 60-aa domain was deleted (ICP8∆60). The
head domain has a conserved hydrophobic region that is defined by the residues F843 and W844
(M. Mapelli, Muhleisen, Persico, van der Zandt, & Tucker, 2000; Marina Mapelli, Panjikar, &
Tucker, 2005).
The work of Darwish et al. suggested that the interaction between two ICP8 molecules is
at least in part mediated by docking of the C-terminal FNF motif into the FW hydrophobic region
(Fig. 3.2). Mutations in the FNF and FW motifs were unable to complement an ICP8-null virus
for viral growth, unable to form RCs in infected cells, unable to form filaments in vitro. They also
had a slight defect in cooperative binding, suggesting that filament formation requires the docking
of the FNF motif into the FW hydrophobic pocket (Darwish et al., 2015). However, we do not
believe that this FNF-FW interaction is the only PPI involved in filament formation. Mapelli et al.
have shown that removal of the 60-aa disordered domain, which includes the FNF linear motif,
causes a severe defect in its cooperative binding (M. Mapelli et al., 2000). This data is consistent
with the suggestion that the FNF motif docks into the FW hydrophobic pocket. Interestingly, the
crystal structure suggests that an additional PPI exists between the C-THD and the concave surface
of the back of neck region of the N-terminal domain. In Figure 6 of Mapelli et al.’s paper, the
researchers depict the interaction between the C-THD with the N-terminal domain of ICP8, and
they predict the residues present in that region that may contact each other (M. Mapelli et al.,
2000). These data provide the basis for further analysis of this second PPI.
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Figure 3.1. ICP8-ICP8 interaction. In this image, created by Katherine DiScipio,
there are two ICP8 molecules. The molecule on the right shows the head (purple),
neck (yellow) and shoulder (gray) regions. It also shows the C-THD (green) and
FW hydrophobic pocket (blue). Missing from the molecule on the right is the 60aa disordered domain that contains the linear FNF motif. The green mass on the left
is a second ICP8 molecule, and the figure shows a C-terminal region, consisting of
a C-THD (green helical), and the 60-aa disordered domain (dotted line) with the
linear FNF motif (star). We believe that during an ICP8-ICP8 interaction, the CTHD of one ICP8 molecule (the molecule on the left) contacts the concave surface
at the back of the head and neck region of a neighboring ICP8 molecule (the
molecule on the right).
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Figure 3.2. FNF motif docks in FW hydrophobic pocket. This figure, an
continuation of Fig. 6 and also created by Katherine DiScipio, highlights
the suggestion by Darwish et al. that the interaction between two ICP8
molecules is mediated by the FNF motif (star) docking into the FW
hydrophobic pocket (blue).
We hypothesize that as ICP8 self-interacts, the C-THD of one ICP8 molecule contacts the
concave surface at the back of the head and neck region of a neighboring ICP8 molecule. Three
pairs of surface-exposed residues visualized in the crystal structure were suggested to promote this
interaction: N839-Y1096, K820-D1094, and D1087-R922 (Fig. 3.3). We have introduced alanine
substitution mutations into each of the six residues and characterized mutants for their ability to
complement the growth of an ICP8 null-virus, HD-2. Alanine substitutions were chosen because
alanine is uncharged, moderately sized, has a non-reactive methyl side chain, retains its beta
carbon, and does not cause conformational changes. Therefore, alanine is a good aa to use to
determine if a specific residue is involved in protein function.
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The putative interaction pair N839 and Y1096 were mutated to test the importance of
hydrogen bonding since asparagine is a polar aa while tyrosine is uncharged. The positive lysine
residue K820, which was proposed to interact with the negative aspartic acid residue D1094, were
mutated to test the importance of electrostatic interactions. D1087, which was proposed to interact
with the positive arginine residue R922, were also mutated to test the importance of electrostatic
interactions. Understanding these interactions will help us better understand the binding properties
of ICP8 and ICP8 protein-protein interactions.

N839 – Y1096
K820 – D1094
D1087– R922

+
+

PDB: 1urj

Figure 3.3. Putative interaction interface. This image, created by Katherine
DiScipio, highlights the interaction pairs that we believe contribute to the
interaction between the concave surface and back of the head and neck region of
ICP8: N839-Y1096 (orange), K820-D1094 (blue), D1087-R922 (red). The box
at the top left corner reveals the location of the interaction pairs within the
concave surface of ICP8 as well as the charges of the residues.
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RESULTS

Mutants express ICP8 and localize protein to the nucleus
In addition to the putative FNF-FW protein-protein interaction suggested by Darwish et
al., we propose that intermolecular interactions between ICP8’s neck and C-THD regions may also
contribute to ICP8-ICP8 interactions. We generated alanine substitution mutations of six
interaction pairs that were suggested to promote this interaction based on the crystal packing
structure: N839-Y1096, K820-D1094, and D1087-R922. The mutant and WT DNA plasmids were
then transiently transfected into Vero cells. Western blot analysis was an analytical technique used
to detect ICP8 and measure the amount of ICP8 expression in our mutant plasmids. Proper
expression of the WT and mutant ICP8 plasmids were confirmed via western blot analysis (Fig.
3.4). IF analysis was used to visualize the distribution of ICP8 protein in the cells transfected with
the mutant plasmids. During both transfection and infection, ICP8 predominantly localizes to the
nucleus. Our IF results confirmed proper nuclear localization of all ICP8 mutants upon transfection
in Vero cells (Fig. 3.5). Together, these results indicate that the mutations did not affect the
localization or global folding/stability of ICP8 in Vero cells.

EV

WT

N839A Y1096A K820A D1094A D1087A R922A

EV

⍺-ICP8
⍺-actin
Figure 3.4. Western blot analysis. The Western blot results reveal great
expression of ICP8 protein by the WT plasmid. In comparison to the WT,
the mutant plasmids also express high levels of ICP8. Actin was used as a
loading control to ensure the protein was loaded equally across all wells.

WT

N839A

D1094A

Y1096A

D1087A

K820A

R922A

Figure 3.5. IF analysis. As visualized in the IF results, these are the
nuclei of transfected cells. The white background of the nuclei is the
localized ICP8 protein. The dark circle(s) within the nucleus is the
nucleolus. The nucleolus is very dense, thus ICP8 is excluded from the
nucleolus.

Mutants K820A, D1087A, and R922A failed to complement viral growth
Darwish et al. observed that ICP8 mutants that lack the ability to form ICP8-ICP8
interactions (such as the FNF->AAA and FW-> AA mutants) are unable to complement the growth
of an ICP8-null virus (Darwish et al., 2015). Therefore, we wanted to test whether our new mutants
in the second proposed PPI interface were able to complement the growth of an ICP8-null virus
(Fig. 3.6). Vero cells were transfected with a mammalian expression vector containing either ICP8
WT or one of the ICP8 mutants and subsequently superinfected with the ICP8-null virus (HD2).
Figure 3.6 shows that mutants N839A, Y1096A, and D1094A exhibited partial complementation
of the null-virus, which suggests that the mutations may not have a dramatic effect on viral growth.
If the mutant does not complement, it can be inferred that some function of ICP8 is being inhibited,
and the mutated residue may be essential for the PPI. Mutants K820A, D1087A, and R922A did
not complement the growth of the ICP8 null-virus. The results from this complementation assay
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demonstrate that residues D1087 and R922 are essential for ICP8 function, and this is consistent
with the hypothesis that they are involved in an essential PPI. The assay also suggests that mutation
of residue K820 may affect the PPI, but the D1094A mutation may still allow the interaction
resulting in the partial complementation phenotype shown in Figure 3.6.
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Figure 3.6. Complementation assay. By definition, WT ICP8 can
complement a null-virus well. Thus, the WT complementation was
defined as 100%. N839A, Y1096A, and D1094A had partial
complementation of the null-virus. K820A, D1087A, and R922A did not
complement growth of the null-virus. This data was averaged from three
independent trials.

Table 1. Summary of protein expression, protein localization, and complementation
assay results. In comparison to WT ICP8, mutants R922A, D1087A, D1094A, K820A, N839A,
and Y1096A expressed ICP8 protein and localized ICP8 to the nucleus. In comparison to WT ICP8
which has 100% complementation, mutants R922A (0%), D0187A (0%) and K820A (1%)
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(highlighted in red) did not complement HD-2 for viral growth while mutants D1094A (48%),
N839A (74%) and Y1096A (24%) had partial complementation.

ICP8
PROTEIN
PROTEIN
MUTANT EXPRESSION LOCALIZATION

%
COMPLEMENTATION

ICP8 WT

Yes

Nuclear

100

R922A

Yes

Nuclear

0

D1087A

Yes

Nuclear

0

D1094A

Yes

Nuclear

48

K820A

Yes

Nuclear

1

N839A

Yes

Nuclear

74

Y1096A

Yes

Nuclear
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Swap and double mutants are defective at viral growth
As mentioned previously, the putative interaction pair D1087A-R922A was mutated to test
the importance of electrostatic interactions. We can infer from our complementation results that
D1087A and R922A are important for ICP8 function because they failed to complement the null
virus. These findings are consistent with the hypothesis that these residues are essential for ICP8ICP8 interaction. To further support the notion that the protein-protein interaction was driven by
electrostatic interactions, we generated a swap mutant (R922D-D1087R). If R922 and D1087
interact predominantly by electrostatic interactions, we would expect that when the charges are
swapped, the electrostatic would be preserved. Thus, we would predict that the swap mutation
would be tolerated; however, to our surprise, the swap mutant did not complement the growth of
HD-2 (Fig. 3.7). It is possible that the swap mutations could have altered an aspect of the
conformation of the protein, resulting in the loss of the interaction. We also generated a double
mutant (R922A-D1087A) for further phenotypic analysis of R922 and D1087 as we wanted to
confirm their proposed contributions to the PPI. The single R922A and D1087A mutants did not
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complement the growth of HD-2, so we would expect the double mutant to exemplify a similar
phenotype. Figure 3.7 shows that as expected, the double mutant was not able to complement the
growth of HD-2. Additional experiments will be necessary to confirm whether R922 and D1087
are involved in electrostatic interactions.

% Complementation (relative to WT
ICP8)

Swap and Double Mutant Average %
Complementation
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ICP8 WT

ICP8 D1087A

ICP8 R922A

ICP8 R922DD1087R (swap)

ICP8 R922AD1087A (double)

Figure 3.7. The complementation assay results for the swap and double mutant were
averaged from 3 trials. Neither the swap or double mutant were able to complement viral
growth. Single mutants D1087A and R922A were included in this assay for comparison.
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DISCUSSION
We hypothesized that the interaction pairs N839-Y1096, K820-D1094, and D1087-R922
contribute to the intermolecular interactions between ICP8’s neck and C-THD regions. Alanine
substitution mutations were generated to test the relevance of these residues to ICP8’s normal
functions. Upon transfection into Vero Cells, western blot analysis determined that mutants
N839A, Y1096A, K820A, D1094A, D1087A, and R922A exhibited similar levels of expression
as the WT version of ICP8. As visualized by IF, all of the mutant proteins localized ICP8 protein
to the nucleus. The complementation assay revealed that mutants N839A, Y1096A, and D1094A
exhibited partial complementation of HD-2, while mutants K820A, D1087A, and R922A were
unable to complement HD-2 for viral growth. Partial complementation is difficult to interpret. It
is possible that these residues are not required for ICP8 function; however, the mutations that we
generated may be too subtle to produce an observable phenotype. Therefore, it may be necessary
to mutate additional residues in these regions to obtain a stronger phenotype. Since mutants
K820A, D1087A, and R922A failed to complement HD-2 for viral growth, we focused on these
mutants for further study.
To determine the roles of K820A, D1087A, and R922A in the ICP8 PPI, additional
experiments will be needed. Katherine DiScipio, a graduate student in the Weller lab, proceeded
with further investigation of the effects of mutants R922A and D1087A on the known biochemical
properties of purified ICP8 protein. Ms. DiScipio constructed a baculovirus containing the
D1087A and R922A mutations and purified the mutant proteins from insect cells as previously
described (Darwish et al., 2015). She was able to characterize these mutant proteins using a series
of biochemical experiments, including an EMSA assay to assess DNA binding, electron
microscopy (EM) to look at filament formation, and an annealing assay. The ssDNA binding assay

results revealed that the mutant proteins could bind DNA but exhibited a defect in cooperative
binding to ssDNA. The EM results, used to visualize double-helical filament formation, showed
that the mutants were unable to form filaments in vitro. Lastly, the annealing assay revealed that
the mutants were slightly defective at annealing but able to promote some annealing at higher
concentrations of ICP8 protein. The region of ICP8 in which R922 and D1087 reside may
contribute more to its cooperative binding and filament formation activities than annealing. This
would explain why annealing activities were preserved and not completely disrupted by mutating
these residues. It is also possible that the annealing assay is not as sensitive as the other assays,
and there is an actual defect in this function. The influence of varying concentrations of ICP8 and
time-courses can be analyzed to test the sensitivity of the annealing assay. Further analysis of
ICP8’s annealing activities will be discussed in Chapter 4.
Similar to the FNF and FW mutants, R922A and D1087A were unable to complement HD2 for viral growth, unable to form filaments in vitro and had a defect in cooperative binding. The
FNF-FW interaction was found to be required for ICP8 filament formation. We can gather from
these results that residues R922 and D1087 are involved in ICP8-ICP8 interactions and contribute
to the interaction between ICP8’s neck and C-THD regions. All in all, the results from this study
suggest that the intermolecular interactions occurring between the neck and C-THD regions of
ICP8 are necessary for ICP8 self-interactions.
The work presented in this chapter suggests that in addition to the FNF-FW interaction,
interactions between the neck and C-THD contribute to ICP8-ICP8 PPIs. Future directions will
involve additional characterization of mutant K820A since it also was not able to complement HD2 for viral growth. K820A could behave similarly to R922A and D1087A in the additional analysis.
K820A could also behave completely different from R922A and D1087A, being that its
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insignificant putative interaction partner, D1094A, did complement HD-2 for viral growth. The
capabilities of R922A and D1087A could solely be due to the residues interacting as a pair. K820A
could potentially interact with a different residue, or it could have the ability to function
individually.
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CHAPTER 4: ICP8 ANNEALING ACTIVITIES DURING HSV DNA REPLICATION
Jaliyah Peterson, Katherine DiScipio, Savithri Weerasooriya, and Renata Szczepaniak
Contributions: J.P. performed Western blot analysis, IF analysis, complementation assay, RC
assay, in-fusion cloning, baculovirus construction, protein purification, and annealing assay. K.D.
performed DNA binding analysis, lead protein purification, assisted with annealing assay, and
prepared samples for qPCR analysis. S.W. ran qPCR, helped with in-fusion cloning, and aided in
cell culture maintenance. R.S. ran qPCR, assisted with cell culture maintenance and in-fusion
cloning.
INTRODUCTION

The HSV viral lifecycle begins with the virus entering the cell. The nucleocapsid is
trafficked to the nucleus, and viral DNA is ejected from the capsid into the nucleus where it
undergoes replication. As the virus replicates, it has to form concatemers to produce viral DNA
that can be packaged into a capsid. As explained in the introduction, concatemer formation is
required for the production of new viral particles. Many dsDNA viruses that replicate through a
concatemer encode their own recombination machinery, including a 5’-3’ exonuclease and a SSAP
(Aravind, Makarova, & Koonin, 2000; Valledor, Hu, Schiller, & Myers, 2012; Weerasooriya et
al., 2019). The phage λ Redα/β is the most commonly known example of an exo/SSAP complex
as it is used frequently in recombination-mediated genetic engineering (Mosberg, Lajoie, &
Church, 2010; Muyrers, Zhang, Testa, & Stewart, 1999; Thomason, Sawitzke, Li, Costantino, &
Court, 2014). The exo/SSAP encoded by HSV consists of UL12 (5’-3’ exonuclease) and ICP8
(SSAP) (Reuven, Staire, Myers, & Weller, 2003; Weerasooriya et al., 2019). ICP8 plays many
different roles during HSV replication; therefore, it has been difficult to discern the importance of
its activity as a SSAP from its other functions as a replicative SSB. However, Weerasooriya et al.
2019 identified an ICP8 mutant, Q706A/F707A, that retained many of the functions associated
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with replicative SSBs but lacked annealing activity. This mutant binds to ssDNA with similar
affinity as WT ICP8 and was able to interact with and stimulate other replication proteins such as
UL9 in vitro; however, it was unable to promoting annealing. Interestingly, this mutant was unable
to complement an ICP8-null virus for viral growth, replication compartment formation, or DNA
synthesis. Together, these data suggest that ICP8 annealing activity is essential for HSV-1 DNA
replication in mammalian cells (Weerasooriya et al., 2019).
A few standing questions remain regarding ICP8
annealing activity: (1) What is the mechanism of ICP8mediated annealing during HSV infection?

(2) What

residues on ICP8 are important for annealing? The

F707
Q706

observations made by Weerasooriya et al. 2019 suggest that
the QF residues are essential for the annealing activity of
ICP8. Q706 and F707 are both conserved residues

Weerasooriya and DiScipio et al., 2019.
PDB: 1URJ

Figure 4.1. QF residues on ICP8
amongst alphaherpesviruses that are located within a structure. This is a ribbon diagram of
ICP8. Pictured is the head (green),
surface-exposed α-helix in the shoulder region of ICP8 neck (yellow), shoulder (light blue)
and C-THD (pink). The QF region is
that is adjacent to the ssDNA binding domain (Fig. 4.1). shown in red.
Therefore, we hypothesize that other conserved residues surrounding the QF region may also be
important for ICP8 annealing activity.
Like the QF residue, which was suggested to be important for annealing, a residue within
another SSAP, gp2.5, was also found to be essential for annealing. This residue resides in a similar
region of the gp2.5 protein as QF does within ICP8, and when mutated, this residue had a very
similar phenotype as the QF mutant. These findings strengthen our hypothesis as we believe we
are analyzing a significant region of the ICP8 protein.
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Weerasooriya et al. and Kazlauskas et al. noticed a structural similarity between ICP8 and
another SSAP, gp2.5 from the T7 phage (Kazlauskas & Eslovas Venclovas, 2012; Weerasooriya
et al., 2019). These two proteins are biochemically similar, they play similar roles during viral
replication, and they both are ssDNA binding proteins that can promote annealing. Structurally,
we see that ICP8 and gp2.5 are similar in that they both possess an oligonucleotide-binding fold
(OB-fold) that is required for binding to ssDNA (A. J. Hernandez & Richardson, 2018; Kazlauskas
& Eslovas Venclovas, 2012; Weerasooriya et al., 2019). This structural similarity can be visualized
by aligning the two protein structures (Fig. 4.2). Comparable to the QF mutant that we found to be
defective for annealing, Rezende et al. have identified a residue in gp2.5 that was also essential for
annealing, R82 (Rezende, Willcox, Griffith, & Richardson, 2003). Similar to the QF mutant, the
R82 mutant (R82C) reportedly lacked annealing activity while maintaining the ability to bind to
ssDNA (Rezende et al., 2003; Weerasooriya et al., 2019). Another interesting fact about R82 is
that it is in a similar position in the T7 phage protein structure as the QF is within the protein
structure of ICP8. Additionally, Fig. 4.2 shows that both proteins lie between a conserved α-helix
(a1) and β-sheet (b3) within the OB-fold. There is also a stretch of highly basic residues in this
region between a1 and b3 relative to the ssDNA binding domain (A. J. Hernandez & Richardson,
2018; Weerasooriya et al., 2019). If we compare ICP8 to gp2.5, we notice that the regions that
seem to be important for annealing are located on similar structural places on the protein. If we
take a closer look at these regions, we also notice that they contain highly basic arginine (R) and
lysine (K) residues. For this reason, we were interested in performing additional analysis of these
conserved, basic R residues with hopes of gaining a better understanding of how ICP8 stimulates
annealing. We hypothesize that conserved residues at the front of the neck and in the shoulder
region of ICP8, located near the QF residues, distinguish domains essential for ssDNA annealing.
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Figure 4.2. Similarities between ICP8 and gp2.5. From top left to top right, this image
shows HSV-1ICP8 protein structure (blue), T7 phage gp2.5 protein structure (red) and the
alignment of the two protein structures (red/blue). Labeled in the structures are β-sheet 2 and
3 and α-helix 1 and 2. Below the structures are the linear sequences of gp2.5 (red) and ICP8
(blue). Within the linear sequence of gp2.5, the R82 (*) residue lies between α-helix 1 and
β-sheet 3. Within this region where R82 is located are a stretch of basic arginine (R) and
lysine (K) residues (circled and highlighted in yellow). The QF (**) residues are also located
between α-helix 1 and β-sheet 3 of ICP8’s linear sequence. The QF residues, like R82, are
surrounded by many arginine and lysine residues (circled and highlighted in yellow). These
structural similarities are the rationale for pursuing the investigation of R residues in this
area. This image was created by Katherine DiScipio.
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RESULTS
R mutants express protein and localize protein to the nucleus
We hypothesized that conserved residues at the front of the neck and in the shoulder region
of ICP8 mark domains essential for ssDNA annealing. To test this hypothesis, we began by
generating alanine substitution mutations of the following R residues: R701, R704, R712, R713,
and R714. As explained in the introduction, these residues were chosen because they lie within a
conserved, basic region of ICP8’s protein structure (Fig. 4.2). We introduced alanine substitution
mutations into a mammalian expression vector. Vero cells were then transfected with WT and
mutant versions of ICP8 to assess protein expression and intracellular localization. If a protein
does not express or localize to the nucleus, this could mean that the protein did not properly fold
into its native structure, preventing it from functioning as normal. Figure 4.3 shows a western blot
of WT and mutant versions of ICP8, indicating that all the mutants expressed wild type levels of
the protein. Although it appears that R704A may exhibit slightly higher levels of expression, we
do not think that this is a significant difference that would affect our future studies. Figure 4.4
shows that all mutants localized protein to the nucleus, suggesting that the mutations did not alter
global conformation.
.
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⍺-ICP8

⍺-actin
Figure 4.3. R residues protein expression. The Western blot results show
that compared to WT ICP8 plasmid, which expresses ICP8 protein, mutants
R701A, R704A, R712A, R713A and R714A express protein as well. Actin
was present as a loading control.
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Figure 4.4. Intracellular localization of WT and mutant ICP8. WT and mutant DNA
plasmids were transfected into Vero cells. The transfected cells were then used in IF
using an ICP8 antibody to visualize localization within the cell. The green background
of the nuclei is localized ICP8 (A). The DNA of the cell is shown in blue (B). Even if
cells are not successfully transfected, the cells should contain DNA. ICP8 and the DNA
are overlapped in the merged image (C).

R701A, R712A, R713A, and R714A did not complement HD-2 viral growth
It is known from the analysis of the QF mutant that if mutations are made that affect
annealing, growth of an ICP8- null virus can no longer be complemented. To determine which R
residues were the most interesting to analyze relative to their function in annealing, we utilized a
complementation assay as a screening tool (Fig. 4.5). The R704A mutant partially complemented
an ICP8-null virus for growth. This suggests that the mutation may not have a dramatic effect on
viral growth. R701A, R712A, R713A, and R714A were quite defective for complementation.
Interestingly, residues R701, R712, R713, and R714 are more exposed on the surface of ICP8
relative to residue R704 (Fig. 4.6). This may indicate that the surface-exposed residues play an
important role in ICP8 function. We have pursued the analysis of R701A, R712A, R713A, and
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R714A and have constructed baculoviruses expressing each of these mutants for protein
purification in insect cells.

Average % Complementation
% Complementation (relative to WT
ICP8)

100
90
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0
ICP8 WT

ICP8 R701A ICP8 R704A ICP8 R712A ICP8 R713A ICP8 R714A

Figure 4.5. R residues complementation assay. The complementation assay results
reveal partial complementation of mutants R704A and R712A and no complementation
from mutants R701A, R713A, and R714A. R712A only had 5% complementation versus
R704A which had about 33% (refer to Table 2). Thus we included R712A in further
analysis but excluded R704A. The average percent complementation was determined
from three independent trials.
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Figure 4.6. R704 location relative to other R residues. This figure, created by
Katherine DiScipio, is showing different angles of where the R residues are located
relative to one another. R704 (green) seems to be slightly in a different location
relative to the other R residues (red). The QF residues (orange) are also present in
this image.
R mutants form replication compartments
HSV-1 DNA replication occurs within sub-domains in the nucleus known as RCs. The
formation of RCs is thought to be dependent on active DNA synthesis. DNA synthesis occurs in
RCs, and the size of the RC correlates approximately to the amount of DNA synthesized (T. J.
Taylor & Knipe, 2004; Travis J Taylor, McNamee, Day, & Knipe, 2003). Since mutants R701A,
R712A, R713A, and R714A were unable to complement the growth of the HD-2, we wanted to
see if RCs could be visualized in cells transfected with WT and mutant versions of ICP8 and
superinfected with HD-2. As shown in the IF results (Fig.4.7), RCs were observed in transfected
cells of the WT plasmid and mutant plasmids. This was a surprising observation since mutants
R701A, R712A, R713A, and R714A did not complement growth; it was expected that there would
be a defect in RC formation. We did, however, expect to see RCs in cells transfected with the
R704A mutant because of its ability to complement HD-2. The RCs in the cells transfected with
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the WT plasmid seemed to be larger than those in cells infected with the mutant plasmids. Since
RCs were formed in cells transfected with these mutants, we predict that some DNA synthesis may
occur in these cells.
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Figure 4.7. RC formation. IF was used to visualize RCs in transfected cells. Cells were
transfected and at ~16-18 hours posttransfection the cells were infected with HD-2 at a
MOI of 20 PFU/cell. RCs were observed in the cells transfected with the WT plasmid
as well as the cells transfected with the mutant proteins (red arrow is pointing to RC in
WT). Cells successfully transfected were identified by green ICP8 staining (A). An antiICP4 antibody, stained in red, was used as a marker of infection (B). The cells’ DNA is
stained in blue (C). All stains were overlapped in the merged image (D).

Table 2. Summary of R residues preliminary data. To summarize the preliminary data,
the mutants expressed ICP8 protein, localized protein to the nucleus, and were able to form RCs.
The main difference we saw was with mutant R704A. This mutant had the greatest average %
complementation, which is why we decided to exclude it from further study to focus on the mutants
that dramatically affect viral growth.
ICP8
MUTANT

PROTEIN
EXPRESSION

PROTEIN
LOCALIZATION

REPLICATION
COMPARTMENT
FORMATION

%
COMPLEMENTATION

ICP8 WT

Yes

Nuclear

Yes

100

R701A

Yes

Nuclear

Yes

0

40

R704A

Yes

Nuclear

Yes

33

R712A

Yes

Nuclear

Yes

5

R713A

Yes

Nuclear

Yes

0

R714A

Yes

Nuclear

Yes

0.29

R mutants synthesize DNA
In order to determine whether the new R mutants were capable of synthesizing viral DNA,
Vero cells were transfected with the WT or mutant ICP8 plasmid. Approximately 16-18 hours
post-transfection, the cells were infected with HD-2 at a MOI of 5 PFU/cell. The cells were
harvested at 24 hours post-infection, and the amount of viral DNA present in the samples was
quantified by qPCR using primers specific for the viral UL9 gene. We used the UL9 gene since
these primers were previously optimized for the detection of viral DNA by qPCR. Katherine
DiScipio, Savithri Weerasooriya, and Renata Szczepaniak performed the qPCR for this study and
analyzed the amounts of DNA synthesized by the R mutants in comparison to WT ICP8.
Levels of viral DNA produced from cells transfected with WT ICP8 plasmid were set at
100%. Figure 4.8 shows that as previously reported, no viral DNA synthesis was observed in cells
transfected with the empty vector or with the QF mutant plasmid (Weerasooriya et al., 2019). On
the other hand, cells transfected with R701A, R712A, R713A, or R714A exhibited some viral
DNA synthesis. R701A, R712A, and R713 exhibited around 20% of WT levels while R714A
displayed less than 5% of WT levels.
These experiments are consistent with the IF results shown in Figure 4.7 and suggest that
the decreased DNA synthesis correlates with the smaller RCs. The DNA synthesis assay also
suggests that the R714A mutant is more defective a producing viral DNA than the other R mutants.
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% Copy # UL9 gene of WT ICP8 transfected
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Figure 4.8. DNA synthesis assay. The DNA synthesis data is represented as % viral DNA
content relative to cells transfected with WT ICP8. The results of the DNA synthesis assay
show that in comparison to the WT ICP8 plasmid, mutants R701A, R712A, R713A and
R714A have little DNA synthesis taking place. Whereas the WT ICP8 plasmid has 100%
of the UL9 gene, the R mutants have ≤ 30% copies of the UL9 gene. This data was averaged
from 2 technical replicates.
Biochemical analysis
To carry out biochemical analysis of viral mutant proteins, they were expressed and
purified using an insect expression system and recombinant baculoviruses. A significant advantage
of using this system is that active ICP8 cannot be purified from E. Coli. Since insect cells are closer
to eukaryotic cells, the protein can be properly folded so that it maintains its activity upon
purification (Grady et al., 2014). Construction of the baculovirus insect cell expression system
began with the cloning of the mutant constructs into the pFastBac donor plasmid. The pFastBacICP8 mutant plasmids were then transformed into DH10Bac cells, and the recombinant bacmid
DNA was purified. SF9 insect cells were transfected with WT or mutant bacmid DNA and left to
incubate for three to four days at 27ºC. The samples were harvested approximately 48-50 hours
post-infection, and expression of the harvested ICP8 mutants’ viral stock was tested during
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titration. Figure 4.9 A shows the uninfected control, and as expected, no ICP8 was observed. Figure
4.9 B-E shows that baculovirus stocks of recombinant viruses expressing mutant ICP8 were able
to express ICP8 protein as seen by the presence of a 128 kDa band. The baculovirus stock
expressing R713A expressed less ICP8 protein when 25-100 uL of virus (lanes #2-4) was used
versus 200-300 uL (lanes #5-6).
Figure 4.9 showed that we could express all mutant versions of ICP8, and in order to
characterize mutant proteins, we have begun protein purification efforts. To date, only the R714A
protein has been purified. This was carried out by infecting 2x106 insect cells/mL with amplified
viral stock. The infected insect cell pellet was resuspended in a lysis buffer, homogenized, and
then resuspended in an extraction buffer to extract nuclear protein. The extracted nuclear protein
was harvested by centrifugation, and the supernatant was collected to undergo dialysis. After
dialysis, the sample was centrifuged once more, filtered, and ran on a Column Hiload 16/10 SPSepharose cation-exchange column. The purified protein fractions were analyzed on a 10% SDSPAGE gel and visualized by Coomassie blue staining, as pictured in Figure 4.10.
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Figure 4.9. Baculovirus stock expression. Baculovirus stocks for mutants R701A,
R712A, R713A and R714A were constructed to be used for protein purification.
The stocks were titrated, as described in the methods, and were tested for ICP8
expression. Lanes #1 and #7 contain the cells only/no viral infection control while
lanes #2-6 and #8-12 contained increasing amounts of viral stock. Lanes #2-6
contained 25 uL, 50 uL, 100 uL, 200 uL, and 300 uL of viral stock, respectively.
Lanes #8-12 also contained 25 uL, 50 uL, 100 uL, 200 uL, and 300 uL of viral
stock, respectively. All mutant viral stocks expressed the 128 kDa ICP8 protein.
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Figure 4.10. R714A Purified Protein Fractions. This is a gel image visualized by
Coomassie blue staining. The total lysate lane contained whole cells which include the cell
membrane, cytoplasmic proteins, and nuclear proteins. Proteins that localize to the cytosol
will appear in the cytoplasmic fraction while proteins that localize to the nucleus will
appear in the nuclear fraction. Highlighted by the red box is the ICP8 protein present in the
infected cells, indicated by the bands being present around the 128 kDa ladder marker. As
shown by the thick band in the nuclear fraction lane, ICP8 protein localized to the nucleus.
After the infected cell pellet was lysed for protein purification, the isolated nuclei were
treated with 1.2 M NaCl to extract ICP8 protein. Since ICP8 is a nuclear localizing protein,
the nuclei has to be eluted with a high salt gradient to ensure that ICP8 binds to the cationexchange column. The cation-exchange column is negatively charged, thus has an affinity
for molecules with net positive surface charges, such as ICP8. The protein fractions were
analyzed on a 10% SDS-PAGE gel and the protein fractions with the highest purity (A7B11), determined by width of the bands, were dialyzed in a storage buffer containing 20
mM HEPES-KOH [pH 7.5], 100 mM NaCl, 10% Glycerol, 1 mM DTT and 0.1 mM EDTA.
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R714A can still anneal complementary ssDNA
Once we obtained the R714A protein, an annealing assay was performed as described
previously by Weerasooriya et al. (Weerasooriya et al., 2019) using PicoGreen, which is a
fluorescent sensor specific for dsDNA. Briefly, ssDNA and ICP8 were incubated in an annealing
buffer for 30 minutes at 37oC. The reaction products were mixed with PicoGreen, and if dsDNA
is formed, the dye will bind to the dsDNA, and there will be a fluorescent signal. The higher the
quantities of dsDNA produced in a reaction, the higher the relative fluorescence units (RFU). The
annealing assay data in Figure 4.11 shows that in the absence of ICP8, very little annealing is
taking place. As the SSAP, ICP8 stimulates annealing, and thus without ICP8, annealing activities
are disrupted. WT ICP8 was able to stimulate annealing of ssDNA in a concentration-dependent
fashion. R714A was also able to stimulate annealing in a concentration-dependent manner. We
observed that more ssDNA was converted to dsDNA as the concentration of ICP8 is increased.
This is in stark contrast to the behavior of the QF mutant, which was not able to promote annealing
(even after prolonged incubation with high concentrations of protein). This may suggest that
residue R714 does not play a direct role in annealing. Alternatively, it is possible that the annealing
assay is not sensitive enough to detect a defect in annealing.
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Figure 4.11. R714A annealing assay. These are the results of our annealing assay.
Four different concentrations of ICP8 protein was used for both the WT and R714A
plasmid (25-200 uM). Time points were taken at 0 and 30 minutes to determine if
the R714A mutant, in comparison to the WT plasmid, promotes annealing over time
with different concentrations of ICP8. A control containing no ICP8 was also
included in the assay. The data was averaged from 3 replicates.
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DISCUSSION
We launched this study with the following research questions: 1.) What residues are
important for annealing? 2.) How does ICP8 promote annealing? By means of these results, we
decided to further explore the QF region with hopes of gaining a better understanding of which
regions of ICP8 are strictly responsible for its SSAP functions. Based on homology to T7 gp2.5,
we hypothesized that conserved arginine residues in this region (R701, R704, R712, R713, and
R714) might be important for annealing.
We began our investigations with Western blot analysis, IF analysis, a complementation
assay, and a RC formation assay. Mutants R701A, R704A, R712A, R713A, and R714A expressed
ICP8 protein, localized protein to the nucleus, and formed RCs. In the complementation assay,
mutant R704A had 33% partial complementation of HD-2 for viral growth, deeming it a nonessential residue to study. Mutants R701A, R712A, R713A, and R714A did not complement/had
very little complementation of HD-2 for viral growth; thus, they were included in additional
analyses. A qPCR analysis revealed that although mutants R701A, R712A, R713A, and R714A
did not complement HD-2 for viral growth, they were still able to synthesize small quantities of
DNA. Upon preparation of the mutants for protein purification, the baculovirus stocks of R701A,
R712A, R713A, and R714A expressed ICP8 protein. R714A protein was purified, and the
annealing activity of R714A was analyzed in an annealing assay. R714A annealed complementary
ssDNA very similar to ICP8 WT. We could infer from these results that mutating R714 does not
drastically affect the annealing capabilities of ICP8. On the other hand, the conditions of the
annealing assay may not have been sensitive enough to depict the annealing activity of the mutant
accurately. Future experimentation would include running a time-course annealing assay using
low protein concentrations to more accurately assess whether R714A has an annealing defect.

The R residues are exposed on the surface of ICP8, and they are distinct from the ssDNA
binding domain. Being that the residues do not directly contact the ssDNA binding pocket, we do
not believe that they will directly affect ssDNA binding; however, the residues may still affect
annealing. They are basic residues that carry a positive charge; therefore, it is possible that they
could be interacting some way with DNA (negatively charged). Additionally, since they are
surface-exposed residues, it is possible that they could be important for mediating an ICP8-ICP8
PPI. Our predictions stem from the phenotypes observed by the QF mutant. The QF residue that
was found to be important for annealing is also within a conserved, surface-exposed α-helix of
ICP8’s shoulder region, and does not directly contact the ssDNA binding pocket. Weerasooriya et
al. reported that the QF mutant was able to bind to ssDNA but was unable to promote annealing.
In a ssDNA binding reaction, visualized by EM, that contained ssDNA without its complementary
DNA strand, ssDNA was coated by ICP8 for the WT and QF mutant. In an ICP8-induced annealing
reaction, also visualized by EM, given both complements of ssDNA, in the presence of a buffer
with Mg+, WT ICP8 displayed the intertwining of the complementary strands of ssDNA. In
contrast, the QF mutant did not display any organized helical structures. An intertwined annealing
intermediate was not formed, and instead, the QF mutant annealing reaction closely resembled its
ssDNA binding reaction (Weerasooriya et al., 2019). These results suggest that the formation of
an annealing intermediate depends on a particular ICP8-ICP8 PPI that is mediated in one way or
another by the shoulder region of ICP8 in which the QF and R residues reside.
Future experimentation would include purifying protein from mutants R701A, R712A, and
R713A. We would then conduct annealing assays for these mutant proteins. In addition, we would
use EM to assess the ability of mutants R701A, R712A, R713A, and R714A to form double-helical
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filaments and annealing intermediates in vitro. We would also use an electrophoretic mobility shift
assay (EMSA) to detect ssDNA binding abilities of the mutant proteins.
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CONCLUSION
In summary, in this chapter, we probed five conserved ICP8 residues in the QF shoulder
region of ICP8 for their roles in annealing. We hypothesized that conserved R residues located
near the QF region mark a domain essential for ICP8 annealing activities. We know that mutants
R701A, R712A, R713A, and R714A cause a defect in viral growth; however, they are still capable
of forming RCs and have small quantities of DNA synthesis taking place. One mutant protein,
R714A, was purified and analyzed in an annealing assay. Compared to the ICP8 WT, this mutant
protein did not have a significant effect on annealing. In order to make more solid conclusions
about the role of these R mutants in ICP8 annealing activities, more experiments have to be
performed. We anticipate that after analyzing all the mutant proteins’ ability to bind ssDNA,
anneal complementary ssDNA, form filaments, and form annealing intermediates, we will gain
valuable insight into the mechanisms by which ICP8 promotes annealing.
In Chapter 3, we mapped residues that contributed to ICP8 filament formation through the
analysis of viral complementation. Our results indicated that residues R922 and D1087 are
involved in ICP8-self interactions but do not play a significant role in ICP8 annealing activities.
Another mutant, K820A, did not complement HD-2 for viral growth even though its pair, D1094A,
was able to. Additional analysis of this mutant will possibly provide another residue that is directly
involved in ICP8-ICP8 interactions.
Together, this work is aiding in the understanding of ICP8 and its central roles in HSV-1
DNA replication. The information provided in this study can help pinpoint elements of the virus’
replication machinery that should be targeted in order to treat HSV-1 in the best capacity.
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